Assessing The Long-Term Safety And To Explore The Long-Term Efficacy Of Zonisamide As Monotherapy In Newly Diagnosed Partial Seizures
NCT00848549
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
295
Enrollment
INDUSTRY
Sponsor class
Conditions
Epilepsy
Interventions
DRUG:
Zonisamide
DRUG:
Carbamazepine
Sponsor
Eisai Inc.